Bioadaptives (BDPT) Net Margin (2016 - 2026)

Bioadaptives has disclosed Net Margin across 9 years of filings, most recently posting 2014.62% for Q1 2026.

• Net Margin for Q1 2026 came in at 2014.62%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 6186.31% (up 11078998.0% YoY), and the FY2025 annual result was 8523.35%, down 142602.0% from the prior year.
• Net Margin came in at 2014.62% for Q1 2026 at Bioadaptives, up from 7896.29% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 265.17% in Q4 2023 to a low of 27113.63% in Q2 2024.
• The 5-year median for Net Margin is 4765.84% (2023), against an average of 5313.43%.
• Across the five-year window, Net Margin sank 2248764 bps in 2024 and surged 2220794 bps in 2025, its largest moves.
• Bioadaptives' Net Margin stood at 973.92% in 2022, then soared by 127 bps to 265.17% in 2023, then plunged by 10325 bps to 27113.63% in 2024, then surged by 71 bps to 7896.29% in 2025, then surged by 74 bps to 2014.62% in 2026.
• The last three Net Margin figures came in at 2014.62% (Q1 2026), 7896.29% (Q4 2025), and 8193.05% (Q3 2025), per Business Quant data.